In a filing, Marker Therapeutics Inc revealed its 10% Owner New Enterprise Associates 16, acquired Company’s shares for reported $1.77 million on Dec 23 ’24. In the deal valued at $3.20 per share,554,250 shares were bought. As a result of this transaction, New Enterprise Associates 16, now holds 1,625,678 shares worth roughly $5.49 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Piper Sandler initiated its Marker Therapeutics Inc [MRKR] rating to an Overweight in a research note published on March 25, 2021; the price target was $6. A number of analysts have revised their coverage, including Cantor Fitzgerald’s analysts, who began to cover the stock in mid March with a ‘”an Overweight”‘ rating. Piper Sandler also remained covering MRKR and has decreased its forecast on May 12, 2020 with a “Neutral” recommendation from previously “an Overweight” rating. ROTH Capital started covering the stock on May 30, 2019. It rated MRKR as “a Buy”.
Price Performance Review of MRKR
On Tuesday, Marker Therapeutics Inc [NASDAQ:MRKR] saw its stock fall -1.17% to $3.38. Over the last five days, the stock has lost -30.45%. Marker Therapeutics Inc shares have fallen nearly -38.55% since the year began. Nevertheless, the stocks have fallen -14.86% over the past one year. While a 52-week high of $6.16 was reached on 07/18/24, a 52-week low of $2.44 was recorded on 10/10/24. SMA at 50 days reached $3.72, while 200 days put it at $3.96.
Levels Of Support And Resistance For MRKR Stock
The 24-hour chart illustrates a support level at 3.20, which if violated will result in even more drops to 3.03. On the upside, there is a resistance level at 3.65. A further resistance level may holdings at 3.93. The Relative Strength Index (RSI) on the 14-day chart is 45.15, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.38, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 95.94%. Stochastics %K at 8.82% indicates the stock is a buying.
How much short interest is there in Marker Therapeutics Inc?
A steep rise in short interest was recorded in Marker Therapeutics Inc stocks on 2024-10-31, growing by 14213.0 shares to a total of 69997.0 shares. Yahoo Finance data shows the prior-month short interest on 2024-09-30 was 55784.0 shares. There was a rise of 20.31%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on March 01, 2019 when Janney began covering the stock and recommended ‘”a Buy”‘ rating .
